Nairobi — UK drugmaker GlaxoSmithKline Limited (GSK) has rebranded to Haleon Kenya Limited, effective March 14, 2025. The rebrand comes after GSK transferred its consumer health business to Haleon to ...

Getting a headache and feeling sick are common side-effects for many medicines. Indulging in risky sexual behavior or ...

Prevalence rates of what GSK calls "deviant" sexual behaviours caused by the drugs are unknown and tend to be under-reported ...

The deal includes two recently approved GSK products for metastatic melanoma ... lucrative and growing sectors in the industry. The UK-headquartered firm says this part of the deal represents ...

Getting a headache and feeling sick are common side-effects for many medicines. Indulging in risky sexual behaviour or pathological gambling – not so common. But a BBC investigation has highlighted ...

Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

The study found that N6LS (VH3810109 or VH109), given every four months in combination with already marketed monthly ...

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, ...

The global nicotine gums and mints market is projected to reach approximately USD 1,536.2 million by the end of 2024, with a ...

A COMMON drug prescribed to treat restless leg syndrome and Parkinson’s can trigger disturbing side effects, experts have warned. Women have come forward reporting how the medicine has led ...